We are live on
!
Find out more
Tudor Investment Corp Portfolio holdings
AUM
$53.9B
1-Year Est. Return
29.12%
This Fund
S&P 500
This Quarter
Est. Return
-1.47%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$19.5B
AUM Growth
+$3.8B
(+24%)
Cap. Flow
+$4.18B
Cap. Flow
% of AUM
21.4%
Top 10 Holdings %
Top 10 Hldgs %
34.26%
Holding
2,929
New
786
Increased
755
Reduced
667
Closed
671
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$122M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$89.5M |
| 3 |
Microsoft
MSFT
|
+$71.3M |
| 4 |
Visa
V
|
+$67M |
| 5 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$61.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$277M |
| 2 |
Micron Technology
MU
|
+$59M |
| 3 |
TCN
Tricon Residential Inc.
TCN
|
+$55.8M |
| 4 |
Zoetis
ZTS
|
+$48.4M |
| 5 |
Amgen
AMGN
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.69% |
| 2 | Industrials | 5.51% |
| 3 | Financials | 5.39% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Healthcare | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
2151
DELISTED
Verve Therapeutics
VERV
| $208K | ﹤0.01% |
42,649
+925
| +2% | +$5.81K |
|
2152
Liquidity Services
LQDT
$1.35B
| $208K | ﹤0.01% |
+10,416
| New | +$195K |
|
2153
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.85B
| $207K | ﹤0.01% |
+2,875
| New | +$202K |
|
2154
US Global Jets ETF
JETS
$832M
| $207K | ﹤0.01% |
10,526
-268
| -2% | -$5.42K |
|
2155
PUT
Corning
GLW
$137B
| $206K | ﹤0.01% |
+5,300
| New | +$185K |
|
2156
PUT
AbbVie
ABBV
$440B
| $206K | ﹤0.01% |
+1,200
| New | +$199K |
|
2157
CALL
Universal Health Services
UHS
$10.2B
| $203K | ﹤0.01% |
+1,100
| New | +$195K |
|
2158
Alta Equipment Group
ALTG
$254M
| $203K | ﹤0.01% |
25,241
-40,008
| -61% | -$405K |
|
2159
iShares MSCI Germany ETF
EWG
$1.67B
| $202K | ﹤0.01% |
+6,604
| New | +$206K |
|
2160
PUT
Prologis
PLD
$134B
| $202K | ﹤0.01% |
1,800
-300
| -14% | -$33.2K |
|
2161
XPeng
XPEV
$11.3B
| $202K | ﹤0.01% |
27,516
-70,243
| -72% | -$555K |
|
2162
Minerals Technologies
MTX
$2.25B
| $201K | ﹤0.01% |
2,422
-41,065
| -94% | -$3.25M |
|
2163
CALL
Lantheus
LNTH
$6.57B
| $201K | ﹤0.01% |
+2,500
| New | +$183K |
|
2164
PUT
Match Group
MTCH
$8.4B
| $201K | ﹤0.01% |
6,600
+600
| +10% | +$19K |
|
2165
INNOVATE Corp
VATE
$105M
| $198K | ﹤0.01% |
32,788
| – | – |
|
2166
CALL
TripAdvisor
TRIP
$1.26B
| $196K | ﹤0.01% |
+11,000
| New | +$239K |
|
|
OPTU
2167
Optimum Communications Inc
OPTU
$227M
| $184K | ﹤0.01% |
90,136
-591,224
| -87% | -$1.31M |
|
2168
Lyell Immunopharma
LYEL
$347M
| $180K | ﹤0.01% |
6,216
+1,916
| +45% | +$91.2K |
|
|
ZYXI
2169
DELISTED
Zynex
ZYXI
| $179K | ﹤0.01% |
19,158
-20,499
| -52% | -$218K |
|
2170
Sumitomo Mitsui Financial
SMFG
$167B
| $178K | ﹤0.01% |
13,289
-127,864
| -91% | -$1.55M |
|
|
GTM
2171
PUT
ZoomInfo Technologies
GTM
$1.12B
| $178K | ﹤0.01% |
+13,900
| New | +$194K |
|
|
OLO
2172
DELISTED
Olo Inc
OLO
| $175K | ﹤0.01% |
+39,630
| New | +$188K |
|
2173
CALL
UiPath
PATH
$8.64B
| $174K | ﹤0.01% |
+13,700
| New | +$237K |
|
2174
Organogenesis Holdings
ORGO
$233M
| $170K | ﹤0.01% |
60,809
-3,504
| -5% | -$9.4K |
|
|
LGTY
2175
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $167K | ﹤0.01% |
+18,341
| New | +$187K |
|
Similar funds
SCP
Tudor Investment Corp's Q2 2024 Portfolio in Review
As of Q2 2024, Tudor Investment Corp held 2,929 positions worth $19.5B, up 24% from $15.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Tudor Investment Corp deployed $4.18B of net new capital in Q2 2024, opening 786 new positions and adding to 755 existing holdings. Its largest new stake was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 8.9% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $59M trimmed.
- Tudor Investment Corp's largest Q2 2024 buy was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
- Tudor Investment Corp added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $122M increase.
- Tudor Investment Corp's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $59M.
- Tudor Investment Corp fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $277M.
- Tudor Investment Corp's ten largest holdings make up 34% of its $19.5B portfolio in Q2 2024.
- Tudor Investment Corp opened 786 new positions and closed 671 in Q2 2024.
- Tudor Investment Corp's portfolio value rose 24% quarter-over-quarter to $19.5B.
Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.